WS
AMED

Wedbush Securities’s Amedisys AMED Stock Holding History

Wedbush Securities’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,446
Closed -$216K – 1173
2021
Q3 		$216K Sell
1,446
-38
-3% -$7.9K 0.01% 1019
2021
Q2 		$363K Buy
1,484
+294
+25% +$77.1K 0.02% 770
2021
Q1 		$315K Sell
1,190
-10
-0.8% -$2.82K 0.02% 794
2020
Q4 		$352K Sell
1,200
-671
-36% -$172K 0.03% 580
2020
Q3 		$442K Buy
1,871
+20
+1% +$4.55K 0.04% 465
2020
Q2 		$367K Buy
1,851
+7
+0.4% +$1.31K 0.03% 534
2020
Q1 		$338K Sell
1,844
-12
-0.6% -$2.13K 0.04% 488
2019
Q4 		$310K Sell
1,856
-6
-0.3% -$892 0.03% 661
2019
Q3 		$244K Buy
1,862
+72
+4% +$9.37K 0.02% 730
2019
Q2 		$217K Buy
+1,790
New +$212K 0.02% 782

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Wedbush Securities's AMED Position: Q4 2021 in Review

Wedbush Securities sold out of Amedisys (AMED) in Q4 2021, closing a stake of 1,446 shares — an estimated $216K sold.

Wedbush Securities first reported a position in AMED in Q2 2019 and held it in 10 quarters. The position peaked at $442K in Q3 2020. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Wedbush Securities reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Wedbush Securities sold 1,446 Amedisys shares in Q4 2021, an estimated $216K.
  • Wedbush Securities first reported a position in Amedisys in Q2 2019 and held it in 10 quarters.
  • Wedbush Securities's Amedisys position peaked at $442K in Q3 2020.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Wedbush Securities's 13F filing for Q4 2021, filed 13 Jan 2022.